Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Progress and prospects: stem cells and neurological diseases

Gene Therapy volume 18, pages 1–6 (2011)Cite this article

Subjects

Abstract

The central nervous system has limited capacity of regenerating lost tissue in slowly progressive, degenerative neurological conditions such as Parkinson's disease (PD), Alzheimer's disease or Huntington's disease (HD), or in acute injuries resulting in rapid cell loss for example, in cerebrovascular damage (for example, stroke) or spinal cord injury. Although the adult brain contains small numbers of stem cells in restricted areas, they do not contribute significantly to functional recovery. Transplantation of stem cells or stem cell-derived progenitors has long been seen as a therapeutic solution to repair the damaged brain. With the advent of the induced pluripotent stem cells technique a new and potentially better source for transplantable cells may be available in future. This review aims to highlight current strategies to replace lost cellular populations in neurodegenerative diseases with the focus on HD and PD and traumatic brain injuries such as stroke, discussing many of the technical and biological issues associated with central nervous system cell transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Zietlow R, Lane EL, Dunnett SB, Rosser AE . Human stem cells for CNS repair. Cell Tissue Res 2008; 331: 301–322.

    Article  PubMed  Google Scholar 

  2. Kim SU, de Vellis J . Stem Cell-Based Cell Therapy in Neurological Diseases: A Review. J Neurosci Res 2009; 87: 2183–2200.

    Article  CAS  PubMed  Google Scholar 

  3. Lovell-Badge R . The regulation of human embryo and stem-cell research in the United Kingdom. Nat Rev Mol Cell Biol 2008; 9: 998–1003.

    Article  CAS  PubMed  Google Scholar 

  4. Mathews DJ, Sugarman J, Bok H, Blass DM, Coyle JT, Duggan P et al. Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology 2008; 71: 288–293.

    Article  CAS  PubMed  Google Scholar 

  5. Anderson L, Burnstein RM, He X, Luce R, Furlong R, Foltynie T et al. Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo. Exp Neurol 2007; 204: 512–524.

    Article  CAS  PubMed  Google Scholar 

  6. Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663–676.

    Article  CAS  PubMed  Google Scholar 

  7. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872.

    Article  CAS  PubMed  Google Scholar 

  8. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917–1920.

    Article  CAS  PubMed  Google Scholar 

  9. Dunnett SB, Rosser AE . Stem cell transplantation for Huntington's disease. Exp Neurol 2007; 203: 279–292.

    Article  CAS  PubMed  Google Scholar 

  10. Krystkowiak P, Gaura V, Labalette M, Rialland A, Remy P, Peschanski M et al. Alloimmunisation to Donor Antigens and Immune Rejection Following Foetal Neural Grafts to the Brain in Patients with Huntington's disease. PLoS One 2007; 1: e166.

    Article  Google Scholar 

  11. Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, Bird TD et al. Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 2007; 68: 2093–2098.

    Article  CAS  PubMed  Google Scholar 

  12. Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, Hevner RF et al. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol 2009; 117: 329–338.

    Article  PubMed  Google Scholar 

  13. Reuter I, Tai YF, Pavese N, Chausdhuri KR, Mason S, Polkey CE et al. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 2008; 79: 948–951.

    Article  CAS  PubMed  Google Scholar 

  14. Capetian P, Knoth R, Maciaczyk J, Pantazis G, Ditter M, Bokla L et al. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 2009; 160: 661–675.

    Article  CAS  PubMed  Google Scholar 

  15. Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, Sanberg PR et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci USA 2009; 106: 12483–12488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Minger SL, Ekonomou A, Carta EM, Chinoy A, Perry RH, Ballard CG . Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2007; 2: 69–74.

    Article  PubMed  Google Scholar 

  17. Ekonomou A, Ballard CG, Pathmanaban ON, Perry RH, Perry EK, Kalaria RN et al. Increased neural progenitors in vascular dementia. Neurobiol Aging 2010. E-pub ahead of print.

  18. Lee HJ, Park IH, Kim HJ, Kim SU . Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage. Gene Ther 2009; 16: 1066–1076.

    Article  CAS  PubMed  Google Scholar 

  19. Lee HJ, Kim K, Park IH, Kim SU . Human Neural Stem Cells Over-Expressing VEGF Provide Neuroprotection, Angiogenesis and Functional Recovery in Mouse Stroke Model. PLoS One 2007; 2: e156.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR . Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 2005; 20: 101–107.

    Article  PubMed  Google Scholar 

  21. Bang OY, Lee JS, Lee PH, Lee G . Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874–882.

    Article  PubMed  Google Scholar 

  22. Andres RH, Choi R, Steinberg GK, Guzman R . Potential of adult neural stem cells in stroke therapy. Regen Med 2008; 3: 893–905.

    Article  PubMed  Google Scholar 

  23. Bliss TM, Andres RH, Steinberg GK . Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010; 37: 275–283.

    Article  PubMed  Google Scholar 

  24. Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S et al. Stem cell therapy in stroke. Cell Mol Life Sci 2009; 66: 757–772.

    Article  CAS  PubMed  Google Scholar 

  25. Nakano-Doi A, Nakagomi T, Fujikawa M, Nakagomi N, Kubo S, Lu S et al. Bone Marrow Mononuclear Cells Promote Proliferation of Endogenous Neural Stem Cells Through Vascular Niches After Cerebral Infarction. Stem Cells 2010; 28: 1292–1302.

    CAS  PubMed  Google Scholar 

  26. Nakagomi N, Nakagomi T, Kubo S, Nakano-Doi A, Saino O, Takata M et al. Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction. Stem Cells 2009; 27: 2185–2195.

    Article  PubMed  Google Scholar 

  27. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010; 4: 488–497.

    Article  Google Scholar 

  28. Yamashita T, Deguchi K, Nagotani S, Kamiya T, Abe K . Gene and stem cell therapy in ischemic stroke. Cell Transplant 2009; 18: 999–1002.

    Article  PubMed  Google Scholar 

  29. Chen B, Gao XQ, Yang CX, Tan SK, Sun ZL, Yan NH et al. Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res 2009; 1284: 1–11.

    Article  CAS  PubMed  Google Scholar 

  30. Lindvall O, Kokaia Z . Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 2009; 30: 260–267.

    Article  CAS  PubMed  Google Scholar 

  31. Isacson O, Kordower JH . Future of cell and gene therapies for Parkinson's disease. Ann Neurol 2008; 64 (Suppl 2): S122–S138.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Li QJ, Tang YM, Liu J, Zhou DY, Li XP, Xiao SH et al. Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene. Synapse 2007; 61: 971–977.

    Article  CAS  PubMed  Google Scholar 

  33. Wijeyekoon R, Barker RA . Cell replacement therapy for Parkinson's disease. Biochim Biophys Acta 2009; 1792: 688–702.

    Article  CAS  PubMed  Google Scholar 

  34. Korecka JA, Verhaagen J, Hol EM . Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease. Regen Med 2007; 2: 425–446.

    Article  CAS  PubMed  Google Scholar 

  35. Deierborg T, Soulet D, Roybon L, Hall V, Brundin P . Emerging restorative treatments for Parkinson's disease. Prog Neurobiol 2008; 85: 407–432.

    Article  CAS  PubMed  Google Scholar 

  36. Maciaczyk J, Singec I, Maciaczyk D, Nikkah G . Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells. Exp Neurol 2008; 213: 354–362.

    Article  CAS  PubMed  Google Scholar 

  37. Roy NS, Cleren C, Singh SK, Yang L, Beal MF, Goldman SA . Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 2006; 12: 1259–1268.

    Article  CAS  PubMed  Google Scholar 

  38. Carpenter M, Rao MS, Freed W, Zeng X . Derivation and characterization of neuronal precursors and dopaminergic neurons from human embryonic stem cells in vitro. Methods Mol Biol 2006; 331: 153–167.

    PubMed  Google Scholar 

  39. Sonntag KC, Pruszak J, Yoshizaki T, van Arensbergen J, Sanchez-Pernaute R, Isacson O . Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells 2007; 25: 411–418.

    Article  CAS  PubMed  Google Scholar 

  40. Friling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E et al. Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA 2009; 106: 7613–7618.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH et al. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 2006; 103: 2874–2879.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London, London, UK

    S Gögel, M Gubernator & S L Minger

Authors
  1. S Gögel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Gubernator
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S L Minger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Gögel.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gögel, S., Gubernator, M. & Minger, S. Progress and prospects: stem cells and neurological diseases. Gene Ther 18, 1–6 (2011). https://doi.org/10.1038/gt.2010.130

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2010.130

Keywords

This article is cited by

Search

Advanced search

Quick links